top

  Info

  • Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.

  Info

  • Utilizzare questo link per rimuovere la selezione effettuata.
Endothelial Dysfunction: From Pathophysiology to Novel Therapeutic Approaches
Endothelial Dysfunction: From Pathophysiology to Novel Therapeutic Approaches
Autore Jeon Byeong Hwa
Pubbl/distr/stampa Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Descrizione fisica 1 electronic resource (368 p.)
Soggetto topico Technology: general issues
Biotechnology
Soggetto non controllato endothelial cells
oxidative stress
inflammageing
endothelial dysfunction
aldehyde dehydrogenase-2
cardiovascular disease
neurovascular disease
vascular inflammation
APE1/Ref-1
cardiovascular diseases
subcellular localization
serological biomarkers
atherosclerosis
aerobic exercise
PCSK9
LOX-1
insulin resistance
macrophage polarity
serum γ-glutamyltransferase
essential hypertension
cardiovascular risk factors
angiogenesis
nargenicin A1
compound 9
VEGF
VEGFR2
HIF-1α
electronegative low-density lipoprotein
LDL(-)
L5 LDL
oxidized LDL
oxLDL
ADMA
arginine
arginine paradox
BH4
blood pressure
COVID-19
dietary supplements
endothelium
eNOS uncoupling
heart failure
hypertension
L-arginine
myocardial infarction
NADPH
nitric oxide
peripheral artery disease
ApoE knockout mouse
atorvastatin
VCAM-1
galectin-3
neutrophil/lymphocyte ratio
electronegative LDL
LDL(−)
lectin-like oxLDL receptor-1
dyslipidemia
chronic venous insufficiency
prolyl oligopeptidase (POP)
inflammation
endothelial disfunction
lung disease
endothelial to mesenchymal transition
pulmonary hypertension
pulmonary fibrosis
metformin
diabetes
CV risk
hyperglycemia
glycated lipoproteins
glycated LDL
glycated HDL
endothelial cell dysfunction
molecular mechanisms
epigenetic factors
therapeutic approaches
vasoactive factors
EndoMT
TGF-β
epigenetics
endothelial cell
glycolysis
metabolism
pathological angiogenesis
tumor microenvironment
MRI (magnetic resonance imaging)
high-fat diets
plaque burden
low-level laser therapy
phototherapy
vascular disease
healing
ischemia
vascular calcification
chronic kidney disease
CKD
uremic toxins
hyperphosphatemia
vascular smooth muscle cells
VSMCs
macrophages
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Altri titoli varianti Endothelial Dysfunction
Record Nr. UNINA-9910566471803321
Jeon Byeong Hwa  
Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Strategies to Improve Antineoplastic Activity of Drugs in Cancer Progression
Strategies to Improve Antineoplastic Activity of Drugs in Cancer Progression
Autore Stefanachi Angela
Pubbl/distr/stampa Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Descrizione fisica 1 electronic resource (416 p.)
Soggetto topico Research & information: general
Biology, life sciences
Soggetto non controllato EGR-1
flavonoid
(E)-5-((4-oxo-4H-chromen-3-yl)methyleneamino)-1-phenyl-1H-pyrazole-4-carbonitrile
MDA-MB-231
MMP9
TNFα
pancreatic ductal adenocarcinoma
cyclodextrin inclusion complex
phase solubility studies
preformulation studies
biphenylnicotinamide derivatives
dual inhibitor
EGFR
VEGFR2
ligand-based pharmacophore
molecular docking
molecular dynamics
leukemias
doxorubicin
inflammation
drug delivery
tumor targeting
elastin-like polypeptide
cell penetrating peptide
matrix metalloproteinase
doxorubicin resistance
photosensitizer delivery system
PAMAM dendrimer
photodynamic therapy
cytotoxicity
phototoxicity
colorectal adenocarcinoma
dicarboximides
chemical synthesis
apoptosis
kinases
anticancer
gene profiling
SAR
biomarkers
colorectal cancer
early detection examination
liquid biopsy
personalized medicine
tumor treatment
exosomes
ctDNA
CTC
cytotoxic activity
pyrazole derivatives
MTT assay
ADMET analysis
single-crystal diffraction
FTIR spectroscopy
NMR spectroscopy thermogravimetric analysis
acute myelogenous leukemia
platelets
microparticles
γδ T cells
immunotherapy
tumor resistance
combination therapy
tumor microenvironment
immune checkpoint inhibitor
neuroblastoma
molecular iodine
cyclophosphamide
xenografts
metronomic therapy
tamoxifen
CYP2D6
MCF-7
Ishikawa cells
SERM
TNBC
uterotrophic
α-mangostin
poly(amidoamine) dendrimer
targeted drug delivery
biotin targeting
glioblastoma multiforme
squamous cell carcinoma
antiparasitic therapy
diclofenac
indomethacin
oleanolic acid derivative conjugates
NF-κB
Nrf2
MAPKs
PSN-1 cells
reactive oxygen species
glioblastoma
brain tumor
extracellular vesicles
pancreatic cancer
paclitaxel
clathrin
endocytosis
sulforaphane
nicotine
metalloproteinase-9
gastric cancer
cell invasion
Arylquin 1
colon cancer
tumor progression
azelastine
oxidative stress
autophagy
mitotic catastrophe
chronic myeloid leukemia
imatinib
tyrosine kinase
ketoconazole
P-glycoprotein
drug efflux transporter
non-small-cell lung cancer
cisplatin resistance
aldehyde dehydrogenase
isothiocyanates
disulfiram
epithelial to mesenchymal transition
aminopeptidase N
acetamidophenones
Schiff bases
semicarbazones
thiosemicarbazones
inhibition of proliferation
ISBN 3-0365-5927-2
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910639990003321
Stefanachi Angela  
Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui